Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $107.1900 (4.29%) ($107.1900 - $107.1900) on Thu. Jan. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.01% (three month average) | RSI | 66 | Latest Price | $107.1900(4.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(51%) IWC(50%) | Factors Impacting LGND price | LGND will decline at least -1.505% in a week (0% probabilities). VIXM(-24%) UUP(-17%) VXX(-15%) UNG(-4%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.505% (StdDev 3.01%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $101.93(5.16%) | 10 Day Moving Average | $102.63(4.44%) | 20 Day Moving Average | $100.16(7.02%) | To recent high | 0% | To recent low | 33.4% | Market Cap | $1.723b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |